Incidence of frailty : a systematic review of scientific literature from a public health perspective
INTRODUCTION: Because of the dynamic nature of frailty, prospective epidemiological data are essential to calibrate an adequate public health response.
METHODS: A systematic review of literature on frailty incidence was conducted within the European Joint Action ADVANTAGE.
RESULTS: Of the 6 studies included, only 3 were specifically aimed at estimating frailty incidence, and only 2 provided disaggregated results by at least gender. The mean follow-up length (1-22.2 years; median 5.1), sample size (74-6306 individuals), and age of participants (≥ 30-65) varied greatly across studies. The adoption of incidence proportions rather than rates further limited comparability of results. After removing one outlier, incidence ranged from 5% (follow-up 22.2 years; age ≥ 30) to 13% (follow-up 1 year, age ≥ 55).
CONCLUSIONS: Well-designed prospective studies of frailty are necessary. To facilitate comparison across studies and over time, incidence should be estimated in person-time rate. Analyses of factors associated with the development of frailty are needed to identify high-risk groups.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:54 |
|---|---|
| Enthalten in: |
Annali dell'Istituto superiore di sanita - 54(2018), 3 vom: 30. Juli, Seite 239-245 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Galluzzo, Lucia [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 01.02.2019 Date Revised 01.02.2019 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.4415/ANN_18_03_11 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM289200636 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM289200636 | ||
| 003 | DE-627 | ||
| 005 | 20231225062027.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.4415/ANN_18_03_11 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0963.xml |
| 035 | |a (DE-627)NLM289200636 | ||
| 035 | |a (NLM)30284551 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Galluzzo, Lucia |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Incidence of frailty |b a systematic review of scientific literature from a public health perspective |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.02.2019 | ||
| 500 | |a Date Revised 01.02.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a INTRODUCTION: Because of the dynamic nature of frailty, prospective epidemiological data are essential to calibrate an adequate public health response | ||
| 520 | |a METHODS: A systematic review of literature on frailty incidence was conducted within the European Joint Action ADVANTAGE | ||
| 520 | |a RESULTS: Of the 6 studies included, only 3 were specifically aimed at estimating frailty incidence, and only 2 provided disaggregated results by at least gender. The mean follow-up length (1-22.2 years; median 5.1), sample size (74-6306 individuals), and age of participants (≥ 30-65) varied greatly across studies. The adoption of incidence proportions rather than rates further limited comparability of results. After removing one outlier, incidence ranged from 5% (follow-up 22.2 years; age ≥ 30) to 13% (follow-up 1 year, age ≥ 55) | ||
| 520 | |a CONCLUSIONS: Well-designed prospective studies of frailty are necessary. To facilitate comparison across studies and over time, incidence should be estimated in person-time rate. Analyses of factors associated with the development of frailty are needed to identify high-risk groups | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Systematic Review | |
| 700 | 1 | |a O'Caoimh, Rónán |e verfasserin |4 aut | |
| 700 | 1 | |a Rodríguez-Laso, Ángel |e verfasserin |4 aut | |
| 700 | 1 | |a Beltzer, Nathalie |e verfasserin |4 aut | |
| 700 | 1 | |a Ranhoff, Anette Hylen |e verfasserin |4 aut | |
| 700 | 1 | |a Van der Heyden, Johan |e verfasserin |4 aut | |
| 700 | 1 | |a Lamprini-Koula, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Ciutan, Marius |e verfasserin |4 aut | |
| 700 | 1 | |a López-Samaniego, Luz |e verfasserin |4 aut | |
| 700 | 1 | |a Liew, Aaron |e verfasserin |4 aut | |
| 700 | 0 | |a Work Package 5 of the Joint Action ADVANTAGE |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annali dell'Istituto superiore di sanita |d 1967 |g 54(2018), 3 vom: 30. Juli, Seite 239-245 |w (DE-627)NLM000417572 |x 2384-8553 |7 nnns |
| 773 | 1 | 8 | |g volume:54 |g year:2018 |g number:3 |g day:30 |g month:07 |g pages:239-245 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.4415/ANN_18_03_11 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 54 |j 2018 |e 3 |b 30 |c 07 |h 239-245 | ||